End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1 SEK | +4.17% | +4.17% | +1.01% |
Apr. 30 | BioInvent Announces Evaluating Attana Technology | CI |
Apr. 25 | Attana AB Enters Third Year of A Five-Year Service and Support Contract with A Leading Health Institute in the US | CI |
Sales 2022 | 13.11M 1.23M | Sales 2023 | 6.82M 640K | Capitalization | 26.99M 2.53M |
---|---|---|---|---|---|
Net income 2022 | -14M -1.31M | Net income 2023 | -13M -1.22M | EV / Sales 2022 | 3.42 x |
Net Debt 2022 | 3.24M 304K | Net Debt 2023 | 3.18M 299K | EV / Sales 2023 | 4.43 x |
P/E ratio 2022 |
-2.84
x | P/E ratio 2023 |
-1.96
x | Employees | 10 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 43.5% |
1 day | +4.17% | ||
1 week | +4.17% | ||
Current month | +23.46% | ||
1 month | +20.48% | ||
3 months | +28.21% | ||
6 months | -42.86% | ||
Current year | +1.01% |
Managers | Title | Age | Since |
---|---|---|---|
Marcus Söderberg
CEO | Chief Executive Officer | - | 23-09-17 |
Founder | 54 | 01-12-31 | |
Anders Ulrikson
DFI | Director of Finance/CFO | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 71 | 16-12-31 | |
Arne Nabseth
CHM | Chairman | 61 | 15-09-30 |
Founder | 54 | 01-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 0.1 | +4.17% | 388,857 |
24-05-23 | 0.096 | +1.05% | 492,273 |
24-05-22 | 0.095 | -6.86% | 195,164 |
24-05-21 | 0.102 | 0.00% | 202,067 |
24-05-20 | 0.102 | +3.03% | 667,979 |
End-of-day quote NORDIC GROWTH MARKET, May 23, 2024
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+1.01% | 3.47M | |
-11.63% | 1.15B | |
-22.77% | 125M | |
-9.84% | 71.28M | |
+1.63% | 58.22M | |
-1.80% | 52.14M |
- Stock Market
- Equities
- ATANA Stock